Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-07-29 15:40:48 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/jco-25-00204
文献链接: https://ascopubs.org/doi/10.1200/JCO-25-00204
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Sarah C. Rutherford; Hongli Li; Alex F. Herrera; Michael LeBlanc; Sairah Ahmed; Kelly Davison; Susan K. Parsons; Joseph M. Unger; Anamarija M. Perry; Carla Casulo; Nancy L. Bartlett; Joseph M. Tuscano; Brian T. Hess; Pallawi Torka; Pankaj Kumar; Ryan Jacobs; Joo Y. Song; Sharon M. Castellino; Brad Kahl; John P. Leonard; Sonali M. Smith; Jonathan W. Friedberg; Andrew M. Evens
